Purolite resins used in drug formulations as APIs or excipients meet the demands of the American (USP), European (Ph.Eur.), British (BP) and Japanese (JP) pharmacopoeias. Drug Master Files are held for each listed pharmaceutical product manufactured in Purolite’s
facilities while resins used in extraction and purification processes, or for the production of water for injectables, meet the requirements of both the US Food and Drug Administration (FDA) and the European Union.
Ion Exchange Chromatography